{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:25:17Z","timestamp":1769106317978,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T00:00:00Z","timestamp":1441843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12978-015-0053-4","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T22:54:30Z","timestamp":1441925670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation"],"prefix":"10.1186","volume":"12","author":[{"given":"Malek Mansour","family":"Aghssa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam Manshadi","family":"Tarafdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensieh Shahrokh","family":"Tehraninejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ezzati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrshad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","volume":"45","author":"KP Tremellen","year":"2005","unstructured":"Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-m\u00fcllerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005;45:20\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"53_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","volume":"83","author":"IA Van Rooij","year":"2005","unstructured":"Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83(4):979\u201387.","journal-title":"Fertil Steril"},{"key":"53_CR3","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","volume":"17","author":"IA van Rooij","year":"2002","unstructured":"van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065\u201371.","journal-title":"Hum Reprod"},{"key":"53_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/humrep\/del421","volume":"22","author":"A La Marca","year":"2007","unstructured":"La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766\u201371.","journal-title":"Hum Reprod"},{"issue":"10","key":"53_CR5","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1210\/jc.2006-0331","volume":"91","author":"WJ Hehenkamp","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91(10):4057\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"53_CR6","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A La Marca","year":"2006","unstructured":"La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103\u20137.","journal-title":"Hum Reprod"},{"issue":"8","key":"53_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/humrep\/deu142","volume":"29","author":"KA Kissell","year":"2014","unstructured":"Kissell KA, Danaher MR, Schisterman EF, Wactawski-Wende J, Ahrens KA, Schliep K, et al. Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29(8):1764\u201372.","journal-title":"Hum Reprod"},{"key":"53_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468\u201371.","journal-title":"Fertil Steril"},{"issue":"1","key":"53_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, Do\u2019lleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354.","journal-title":"Hum Reprod Update"},{"key":"53_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-EL R, Herman A, Sofer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Survey. 1989;44:430\u201340.","journal-title":"Obstet Gynecol Survey"},{"key":"53_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","volume":"58","author":"D Navot","year":"1992","unstructured":"Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58:249\u201361.","journal-title":"Fertil Steril"},{"issue":"7","key":"53_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/aje\/kwj063","volume":"163","author":"NJ Perkins","year":"2006","unstructured":"Perkins NJ, Schisterman EF. The Inconsistency of \u201cOptimal\u201d Cut-points Using Two ROC Based Criteria. Am J Epidemiol. 2006;163(7):670\u20135.","journal-title":"Am J Epidemiol"},{"key":"53_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","volume":"139","author":"T McLaughlin","year":"2003","unstructured":"McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant. Ann Intern Med. 2003;139:802\u20139.","journal-title":"Ann Intern Med"},{"key":"53_CR14","first-page":"10","volume":"31","author":"GT Lainas","year":"2012","unstructured":"Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Tarlatzi TB, et al. Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study. Reprod Biol Endocrinol. 2012;31:10\u201369.","journal-title":"Reprod Biol Endocrinol"},{"key":"53_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ajog.2008.05.004","volume":"199","author":"RM Riggs","year":"2008","unstructured":"Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, et al. Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008;199:202\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"53_CR16","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013 implications for individualization of therapy. Hum Reprod. 2007;22:2414\u201321.","journal-title":"Hum Reprod"},{"key":"53_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160\u20137.","journal-title":"Hum Reprod"},{"key":"53_CR18","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1093\/humrep\/dei203","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Ben Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20:3178\u201383.","journal-title":"Hum Reprod"},{"key":"53_CR19","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","volume":"92","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92:1586\u201393.","journal-title":"Fertil Steril"},{"key":"53_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","volume":"26","author":"A Aflatoonian","year":"2009","unstructured":"Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2\u20136\u00a0mm). J Assist Reprod Genet. 2009;26:319\u201325.","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"53_CR21","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/humrep\/del127","volume":"21","author":"T Ebner","year":"2006","unstructured":"Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-M\u00fcllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21(8):2022\u20136.","journal-title":"Hum Reprod"},{"issue":"2","key":"53_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"53_CR23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10815-012-9880-1","volume":"29","author":"HW Li","year":"2012","unstructured":"Li HW, Ng EH, Wong BP, Anderson RA, Ho PC, Yeung WS. Correlation between three assay systems for anti-M\u00fcllerian hormone (AMH) determination.J. J Assist Reprod Genet. 2012;29(12):1443\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"53_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1472-6483(10)60452-X","volume":"12","author":"JA Garcia-Velasco","year":"2009","unstructured":"Garcia-Velasco JA. How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists. Reprod BioMed Online. 2009;12:71\u20135.","journal-title":"Reprod BioMed Online"},{"key":"53_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3109\/00016340903287482","volume":"88","author":"A Kahnberg","year":"2009","unstructured":"Kahnberg A, Enskog A, Brannstrom M, Lundin K, Bergh C. Prediction of ovarian hyperstimulation syndrome in women undergoingin vitro fertilization. Acta Obstetricia et Gynecologica. 2009;88:1373\u201381.","journal-title":"Acta Obstetricia et Gynecologica"},{"key":"53_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.2146\/ajhp070566","volume":"65","author":"P Aramwit","year":"2008","unstructured":"Aramwit P, Pruksananonda K, Kasettratat N, Jammeechai K. Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization. J Health-Syst Pharm. 2008;65:1148\u201353.","journal-title":"J Health-Syst Pharm"},{"key":"53_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10815-010-9427-2","volume":"27","author":"S Kini","year":"2010","unstructured":"Kini S, Raymond HW, Morrell D, Pickering S, Thong KJ. Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization. J Asist Reprod Genet. 2010;27:449\u201356.","journal-title":"J Asist Reprod Genet"},{"issue":"S1","key":"53_CR28","doi-asserted-by":"publisher","first-page":"s16","DOI":"10.1097\/01.PAT.0000461378.05886.9e","volume":"47","author":"G Ward","year":"2015","unstructured":"Ward G. AMH \u2013 where are we up to? Pathology. 2015;47(S1):s16.","journal-title":"Pathology"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-015-0053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12978-015-0053-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-015-0053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-015-0053-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:53:56Z","timestamp":1630608836000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-015-0053-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1186\/s12978-015-0053-4","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]},"assertion":[{"value":"2 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"85"}}